β3-Endonexin as a Novel Inhibitor of Cyclin A-Associated Kinase
- 27 January 2000
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 267 (3) , 947-952
- https://doi.org/10.1006/bbrc.1999.2007
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim Japan
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 33 references indexed in Scilit:
- pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2FOncogene, 1998
- Affinity Modulation of Platelet Integrin αIIbβ3 by β3-Endonexin, a Selective Binding Partner of the β3 Integrin Cytoplasmic TailThe Journal of cell biology, 1997
- A Conserved Sequence Motif in the Integrin β3 Cytoplasmic Domain Is Required for Its Specific Interaction with β3-EndonexinPublished by Elsevier ,1997
- Cyclin/Cdk-Dependent Initiation of DNA Replication in a Human Cell-Free SystemPublished by Elsevier ,1997
- Beta 3-endonexin, a novel polypeptide that interacts specifically with the cytoplasmic tail of the integrin beta 3 subunit.The Journal of cell biology, 1995
- p21 is a universal inhibitor of cyclin kinasesNature, 1993
- A Link Between Cyclin A Expression and Adhesion-Dependent Cell Cycle ProgressionScience, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Reversal of terminal differentiation and control of DNA replication: Cyclin A and cdk2 specifically localize at subnuclear sites of DNA replicationCell, 1993
- Cell Cycle Control of DNA Replication by a Homologue from Human Cells of the p34
cdc2
Protein KinaseScience, 1990